COR

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under CMS FY 2026 Medicare's Part B physician fee schedule. Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R.4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Preventing and Mitigating Generic Drug Shortages CMS FY 2026 Medicares Part B Physician Fee Schedule: Proposed Changes to Bonafide Service Fees Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile

Issues related to trade Issues related to health care and pharmaceutical industry

Issues related to Healthcare Reform. The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues. The FY2027 National Defense Authorization Act (No Bill Number): issues related to DoDs supply of essential and lifesaving medicines.

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Extend payment increase under Medicare's physician fee schedule. Reimbursement policies impacting drug shortages Preventing and Mitigating Generic Drug Shortages Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)

H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.

Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory

Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)

IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.

Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug shortages and national stockpiles at the U. S. Department of War. Issues related to corporate taxation.

HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule.